These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33485619)

  • 21. Postoperative imaging surveillance for hepatocellular carcinoma: How much is enough?
    Mirdad RS; Madison Hyer J; Diaz A; Tsilimigras DI; Azap RA; Paro A; Pawlik TM
    J Surg Oncol; 2021 Jun; 123(7):1568-1577. PubMed ID: 33596330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Payer-Negotiated Price Variation and Relationship to Surgical Outcomes for the Most Common Cancers at NCI-Designated Cancer Centers.
    Sankaran R; O'Connor J; Nuliyalu U; Diaz A; Nathan H
    Ann Surg Oncol; 2024 Jul; 31(7):4339-4348. PubMed ID: 38506934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical therapy for early hepatocellular carcinoma in the modern era: a 10-year SEER-medicare analysis.
    Nathan H; Hyder O; Mayo SC; Hirose K; Wolfgang CL; Choti MA; Pawlik TM
    Ann Surg; 2013 Dec; 258(6):1022-7. PubMed ID: 23299519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gamma-glutamyl transpeptidase to platelet ratio predicts short-term outcomes in hepatocellular carcinoma patients undergoing minor liver resection.
    Ke MY; Zhang M; Su Q; Wei S; Zhang J; Wang Y; Wu R; Lv Y
    J Surg Res; 2018 Nov; 231():403-410. PubMed ID: 30278960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Breast Center Accreditation on Compliance with Breast Quality Performance Measures at Commission on Cancer-Accredited Centers.
    Miller ME; Bleicher RJ; Kaufman CS; Kurtzman SH; Chang C; Wang CH; Pollitt KA; Connolly J; Winchester DP; Yao KA
    Ann Surg Oncol; 2019 May; 26(5):1202-1211. PubMed ID: 30684159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Commission on Cancer Accreditation on Cancer Survival: A Surveillance, Epidemiology, and End Results (SEER) Database Analysis.
    Ahmed A; Whittington J; Shafaee Z
    Ann Surg Oncol; 2024 Apr; 31(4):2286-2294. PubMed ID: 38093167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibrosis score impacts survival following resection for hepatocellular carcinoma (HCC): A Surveillance, End Results and Epidemiology (SEER) database analysis.
    Kamarajah SK
    Asian J Surg; 2018 Nov; 41(6):551-561. PubMed ID: 29454570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oncological Outcomes of Hepatic Resection vs Transplantation for Localized Hepatocellular Carcinoma.
    Akcam AT; Saritas AG; Ulku A; Rencuzogullari A
    Transplant Proc; 2019 May; 51(4):1147-1152. PubMed ID: 31101189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thermal Ablation versus Surgical Resection for the Treatment of Stage T1 Hepatocellular Carcinoma in the Surveillance, Epidemiology, and End Results Database Population.
    Mironov O; Jaberi A; Kachura JR
    J Vasc Interv Radiol; 2017 Mar; 28(3):325-333. PubMed ID: 28073607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends in perioperative outcomes of hospitals performing major cancer surgery.
    Liu JB; Berian JR; Liu Y; Ko CY; Weber SM
    J Surg Oncol; 2018 Sep; 118(4):694-703. PubMed ID: 30129674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness and cost of radiofrequency ablation and stereotactic body radiotherapy for treatment of early-stage hepatocellular carcinoma: An analysis of SEER-medicare.
    Parikh ND; Marshall VD; Green M; Lawrence TS; Razumilava N; Owen D; Singal AG; Feng M
    J Med Imaging Radiat Oncol; 2018 Oct; 62(5):673-681. PubMed ID: 29877615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does hospital accreditation impact bariatric surgery safety?
    Morton JM; Garg T; Nguyen N
    Ann Surg; 2014 Sep; 260(3):504-8; discussion 508-9. PubMed ID: 25115426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Portal hypertension predicts short-term and long-term outcomes after hepatectomy in hepatocellular carcinoma patients.
    Zheng YW; Wang KP; Zhou JJ; Zhang ZQ; Xiong L; Wen Y; Zou H
    Scand J Gastroenterol; 2018 Dec; 53(12):1562-1568. PubMed ID: 30572742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utilizing Machine Learning for Pre- and Postoperative Assessment of Patients Undergoing Resection for BCLC-0, A and B Hepatocellular Carcinoma: Implications for Resection Beyond the BCLC Guidelines.
    Tsilimigras DI; Mehta R; Moris D; Sahara K; Bagante F; Paredes AZ; Farooq A; Ratti F; Marques HP; Silva S; Soubrane O; Lam V; Poultsides GA; Popescu I; Grigorie R; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Pawlik TM
    Ann Surg Oncol; 2020 Mar; 27(3):866-874. PubMed ID: 31696396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival and cost-effectiveness of sorafenib therapy in advanced hepatocellular carcinoma: An analysis of the SEER-Medicare database.
    Parikh ND; Marshall VD; Singal AG; Nathan H; Lok AS; Balkrishnan R; Shahinian V
    Hepatology; 2017 Jan; 65(1):122-133. PubMed ID: 27770556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A meta-analysis of bariatric surgery-related outcomes in accredited versus unaccredited hospitals in the United States.
    Baidwan NK; Bachiashvili V; Mehta T
    Clin Obes; 2020 Feb; 10(1):e12348. PubMed ID: 31713328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver resection for hepatocellular carcinoma in patients with metabolic syndrome: A multicenter matched analysis with HCV-related HCC.
    Viganò L; Conci S; Cescon M; Fava C; Capelli P; D'Errico A; Torzilli G; Di Tommaso L; Giuliante F; Vecchio FM; Salizzoni M; David E; Pinna AD; Guglielmi A; Capussotti L
    J Hepatol; 2015 Jul; 63(1):93-101. PubMed ID: 25646890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mortality assessment of patients with hepatocellular carcinoma according to underlying disease and treatment modalities.
    Golabi P; Fazel S; Otgonsuren M; Sayiner M; Locklear CT; Younossi ZM
    Medicine (Baltimore); 2017 Mar; 96(9):e5904. PubMed ID: 28248853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transplantation versus resection for patients with combined hepatocellular carcinoma-cholangiocarcinoma.
    Groeschl RT; Turaga KK; Gamblin TC
    J Surg Oncol; 2013 May; 107(6):608-12. PubMed ID: 23386397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Mechanical Bowel Preparation on Postoperative Outcomes after Liver Resection for Patients with Hepatocellular Carcinoma: A Single-Center Retrospective Cohort Study.
    Hokuto D; Nomi T; Yamato I; Yasuda S; Obara S; Nakajima Y
    Dig Surg; 2016; 33(1):51-7. PubMed ID: 26587899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.